Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo
Tobias Thom(German Center for Neurodegenerative Diseases), Inga Zerr(Universitätsmedizin Göttingen), Franc Llorens(Bellvitge University Hospital), Erik Stoops(ADx NeuroSciences), Susana Correia(University of Göttingen), Saima Zafar(German Center for Neurodegenerative Diseases), André Fischer(German Center for Neurodegenerative Diseases), Renato Domingues(Universitätsmedizin Göttingen), Christopher J. Silva(Agricultural Research Service), Anna‐Villar Pique(German Center for Neurodegenerative Diseases), Angela da Silva Correia(German Center for Neurodegenerative Diseases), Anna‐Lisa Fischer(German Center for Neurodegenerative Diseases), Matthias Schmitz(University of Göttingen), Wiebke Möbius(Max Planck Institute of Experimental Medicine), Tiago F. Outeiro(German Center for Neurodegenerative Diseases)
Cited by 29
Related Papers
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
|Annals of Neurology|1999|1.4k
Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease
|Science|2007|1.1k
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
|The Lancet Neurology|2024|499
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected
|EMBO Molecular Medicine|2020|411
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
|PLoS ONE|2008|410